Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA

Journal of Liposome Research

Volumn 23, Issue 1, 2013, Pages 1-10

  Bai, Jing ^a   Zhou, Zhengyuan ^a   Tang, Hailing ^a   Song, Shuxian ^a   Peng, Jinliang ^a   Xu, Yuhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gene delivery; Lipoplex; Peg density; PEGylation; Pharmacokinetic

Indexed keywords

LIPID; LIPID MU PEPTIDE DNA NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER LOCALIZATION; DENSITY; DISTRIBUTION VOLUME; FLUORESCENCE; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PROPERTY; TIME; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; WHOLE BODY IMAGING; ZETA POTENTIAL;

ANIMALS; DNA; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; LIPIDS; LIPOSOMES; MICE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; PEPTIDES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873296059     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.708934     Document Type: Article

References (38)

1. Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L.; MacLachlan, I. (2005). Stabilized plasmid-lipid particles containing PEGdiacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta 1669:155-163. (Pubitemid 40704733)
2. Burvenich, I., Schoonooghe, S., Cornelissen, B., Blanckaert, P., Coene, E., Cuvelier, C., Mertens, N., et al. (2005). In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. Clin Cancer Res 11:7288-7296. (Pubitemid 41507686)
3. Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 63:19-30. (Pubitemid 30046939)
4. Diagaradjane, P., Orenstein-Cardona, J. M., Colon-Casasnovas, N. E., Deorukhkar, A., Shentu, S., Kuno, N., et al. (2008). Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 14:731-741. (Pubitemid 351231154)
5. Dos Santos, N., Allen, C., Doppen, A. M., Anantha, M., Cox, K. A., Gallagher, R. C., et al. (2007). Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta 1768:1367-1377. (Pubitemid 46782695)
6. Fu, J., Li, D., Xia, S., Song, H., Dong, Z., Chen, F., et al. (2009). Absolute quantification of plasmid DNA by real-time PCR with genomic DNA as external standard and its application to a biodistribution study of an HIV DNA vaccine. Anal Sci 25:675-680.
7. Fundaro, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., Gasco, M. R. (2000). Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res 42:337-343.
8. Gillies, E. R., Dy, E., Frechet, J. M., Szoka, F. C. (2005). Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Mol Pharm 2:129-138. (Pubitemid 41295360)
9. He, X. Q., Chen, G. M., Huang, Y., Yang, F. Q., Wu, L. Y., Mo, G. Y. (2003). Construction and identification of therapeutic double plasmid HBV DNA vaccine. Med J Chin PLA 28:493-497.
10. Heyes, J., Palmer, L., Chan, K., Giesbrecht, C., Jeffs, L., MacLachlan, I. (2007). Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther 15:713-720. (Pubitemid 46431991)
11. Ishida, T., Iden, D. L., Allen, T. M. (1999). A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 460:129-133. (Pubitemid 29479257)
12. Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., et al. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anticarcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 65:622-631.
13. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K. L., Nielsen, U. B., et al. (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66:6732-6740. (Pubitemid 44085631)
14. Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235-237. (Pubitemid 20233874)
15. Kostarelos, K., Miller, A. D. (2005). Synthetic, self-assembly ABCD nanoparticles: a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 34:970-994. (Pubitemid 41619247)
16. Lee, C. M., Choi, Y., Huh, E. J., Lee, K. Y., Song, H. C., Sun, M. J., et al. (2005). Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation. Cancer Biother Radiopharm 20:620-628. (Pubitemid 43099612)
17. Li, S. D., Chen, Y. C., Hackett, M. J., Huang, L. (2008). Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 16:163-169.
18. Li, S., Huang, L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4:891-900. (Pubitemid 27437714)
19. Li, S. D., Huang, L. (2006). Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci 1082:1-8. (Pubitemid 44955442)
20. Li, S. D., Huang, L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496-504.
21. Lim, J., Guo, Y., Rostollan, C. L., Stanfield, J., Hsieh, J. T., Sun, X. K., et al. (2008). The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Mol Pharm 5:540-547.
22. Medarova, Z., Pham, W., Farrar, C., Petkova, V., Moore, A. (2007). In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 13:372-377. (Pubitemid 46376679)
23. Moghimi, S. M., Hunter, A. C., Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283-318. (Pubitemid 32476118)
24. Moghimi, S. M., Szebeni, J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463-478. (Pubitemid 37237636)
25. Mosqueira, V. C., Legrand, P., Morgat, J. L., Vert, M., Mysiakine, E., Gref, R., et al. (2001). Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res 18:1411-1419. (Pubitemid 32977246)
26. Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., et al. (2004). Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169-183. (Pubitemid 38720414)
27. Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., Murthy, R. S. R. (2005). Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J Control Release 105:185-198. (Pubitemid 40941985)
28. Sokolov, K., Follen, M., Aaron, J., Pavlova, I., Malpica, A., Lotan, R., et al. (2003). Real-time vital optical imaging of precancer using antiepidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63:1999-2004. (Pubitemid 36538596)
29. Song, S., Liu, D., Peng, J., Deng, H., Guo, Y., Xu, L. X., et al. (2009). Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo. FASEB J 23:1396-1404.
30. Tagawa, T., Manvell, M., Brown, N., Keller, M., Perouzel, E., Murray, K. D., et al. (2002). Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu, and plasmid DNA. Gene Ther 9:564-576. (Pubitemid 34567773)
31. Torchilin,V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532-1555. (Pubitemid 44822608)
32. Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Jr., Trubetskoy, V. S., Herron, J. N., et al. (1994). Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195:11-20. (Pubitemid 24318086)
33. Veiseh, M., Gabikian, P., Bahrami, S. B., Veiseh, O., Zhang, M., Hackman, R. C., et al. (2007). Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67:6882-6888. (Pubitemid 47105535)
34. Wang, C. H., Liu, C. J., Wang, C. L., Hua, T. E., Obliosca, J. M., Lee, K. H., et al. (2008). Optimizing the size and surface properties of polyethylene glycol (PEG)-gold nanoparticles by intense x-ray irradiation. J Phys Appl Phys 41:1-8.
35. Wong, H. L., Bendayan, R., Rauth, A. M., Li, Y., Wu, X. Y. (2007). Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 59:491-504. (Pubitemid 47259227)
36. Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., Yang, C. Z. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 59:299-307. (Pubitemid 29238174)
37. Zara, G. P., Cavalli, R., Bargoni, A., Fundaro, A., Vighetto, D., Gasco, M. R. (2002). Intravenous administration to rabbits of nonstealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target 10:327-335. (Pubitemid 34746314)
38. Zimmermann, T. S., Lee, A. C., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., et al. (2006). RNAi-mediated gene silencing in non-human primates. Nature 441:111-114.